These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1327746)

  • 1. Excitatory amino acids in epilepsy and potential novel therapies.
    Meldrum BS
    Epilepsy Res; 1992 Jul; 12(2):189-96. PubMed ID: 1327746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate metabotropic receptors as targets for drug therapy in epilepsy.
    Moldrich RX; Chapman AG; De Sarro G; Meldrum BS
    Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory amino acid transmitters in epilepsy.
    Meldrum BS
    Epilepsia; 1991; 32 Suppl 2():S1-3. PubMed ID: 1723042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptors in epilepsy.
    Chapman AG
    Prog Brain Res; 1998; 116():371-83. PubMed ID: 9932389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmission in epilepsy.
    Meldrum BS
    Epilepsia; 1995; 36 Suppl 1():S30-5. PubMed ID: 23057108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitatory amino acids in epilepsy and novel anti-epileptic drugs.
    Chapman A; Meldrum B
    Epilepsy Res Suppl; 1991; 3():39-48. PubMed ID: 1685650
    [No Abstract]   [Full Text] [Related]  

  • 7. Glutamatergic Mechanisms Associated with Seizures and Epilepsy.
    Barker-Haliski M; White HS
    Cold Spring Harb Perspect Med; 2015 Jun; 5(8):a022863. PubMed ID: 26101204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy.
    Casillas-Espinosa PM; Powell KL; O'Brien TJ
    Epilepsia; 2012 Dec; 53 Suppl 9():41-58. PubMed ID: 23216578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate and epilepsy.
    Chapman AG
    J Nutr; 2000 Apr; 130(4S Suppl):1043S-5S. PubMed ID: 10736378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism based approaches to anticonvulsant therapies: modulation of inhibitory and excitatory transmission.
    Meldrum B
    Prog Clin Biol Res; 1990; 361():31-43. PubMed ID: 1981259
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticonvulsive drug therapy. Historical and current aspects].
    Bauer J; Elger CE
    Nervenarzt; 1995 Jun; 66(6):403-11. PubMed ID: 7543658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic aspects of epilepsy.
    Löscher W
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):223-32. PubMed ID: 8097638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats.
    De Sarro G; De Sarro A
    Eur J Pharmacol; 1992 May; 215(2-3):221-9. PubMed ID: 1396987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.
    Meldrum BS; Craggs MD; Dürmüller N; Smith SE; Chapman AG
    Epilepsy Res Suppl; 1992; 9():307-11. PubMed ID: 1337444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glutamate receptor antagonists as potential antiepileptic drugs].
    Czuczwar SJ
    Neurol Neurochir Pol; 2000; 34 Suppl 8():41-6. PubMed ID: 11780588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
    De Sarro G; De Sarro A; Ammendola D; Patel S
    Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triazolines--XXVII. delta2-1,2,3-triazoline anticonvulsants: novel 'built-in' heterocyclic prodrugs with a unique 'dual-action' mechanism for impairing excitatory amino acid L-glutamate neurotransmission.
    Kadaba PK; Stevenson PJ; P-Nnane I; Damani LA
    Bioorg Med Chem; 1996 Feb; 4(2):165-78. PubMed ID: 8814876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic motor-evoked potentials in epilepsy: effects of the disease and of anticonvulsant medication.
    Hufnagel A; Elger CE; Marx W; Ising A
    Ann Neurol; 1990 Nov; 28(5):680-6. PubMed ID: 2175574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glutamate in epilepsy and other CNS disorders.
    Meldrum BS
    Neurology; 1994 Nov; 44(11 Suppl 8):S14-23. PubMed ID: 7970002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.